Omolola Adepoju to Cost-Benefit Analysis
This is a "connection" page, showing publications Omolola Adepoju has written about Cost-Benefit Analysis.
Connection Strength
0.149
-
Adepoju OE, Bolin JN, Ohsfeldt RL, Phillips CD, Zhao H, Ory MG, Forjuoh SN. Can chronic disease management programs for patients with type 2 diabetes reduce productivity-related indirect costs of the disease? Evidence from a randomized controlled trial. Popul Health Manag. 2014 Apr; 17(2):112-20.
Score: 0.097
-
Janda K, King B, Adepoju O, Chavez S, Bejarano G, Braun RT, Ho V, Liaw W. Consolidation in an Era of Population Health and Value-Based Care: Implications for Effectiveness, Costs, and Equity. Med Care. 2025 Apr 01; 63(4):267-269.
Score: 0.053